ArticleAlimentary pharmacology & therapeutics2022

Antibodies-to-infliximab accelerate clearance while dose intensification reverses immunogenicity and recaptures clinical response in paediatric Crohn's disease.

Ruben J Colman et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.